Apr 12 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Feb 28, 2017 Feb 29, 2016 May 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 370.57 327.80 490.00
(+13.0 pct) (+8.2 pct) (+9.6 pct)
Operating 17.37 13.42 18.70
(+29.4 pct) (+10.8 pct) (+0.3 pct)
Recurring 19.11 14.93 20.70
(+28.0 pct) (+9.6 pct) (+0.0 pct)
Net 12.58 9.20 13.50
(+36.7 pct) (+12.8 pct) (+8.6 pct)
EPS 635.36 yen 464.77 yen 681.83 yen
Ann Div 65.00 yen 70.00 yen
-Q2 div 35.00 yen 30.00 yen
-Q4 div 35.00 yen 35.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T
((Tokyo Headline News Desk +813 6441 1812))